Dissolution & Release Test

Dissolution and release testing stand as cornerstone quality control pillars in pharmaceutical development, bridging in vitro performance and in vivo efficacy. For solid oral dosage forms—including tablets, capsules, and modified-release formulations—this test quantifies the rate and extent of active pharmaceutical ingredient (API) release into simulated gastrointestinal fluids, directly correlating to bioavailability and therapeutic outcomes. In an era of stringent global regulatory standards, reliable dissolution data is non-negotiable: it validates formulation consistency, detects manufacturing variations, supports biopharmaceutics classification system (BCS) evaluations, and ensures batch-to-batch uniformity throughout a product's lifecycle. Without rigorous dissolution testing, drugs may fail to release APIs at the intended rate, leading to reduced efficacy, unexpected adverse effects, or failed regulatory submissions. For pharmaceutical innovators and contract development and manufacturing organizations (CDMOs), robust dissolution testing is not just a compliance requirement but a critical enabler of safe, effective drug delivery to patients worldwide.

Global Regulatory Standards for Dissolution/Release Testing

PharmaAnalytica's dissolution/release testing services adhere to the most stringent international pharmacopeial and regulatory frameworks, ensuring full compliance with global market access requirements. Our testing protocols align with:

• United States Pharmacopeia (USP) <711> (Dissolution) and <724> (Drug Release), including guidance for modified-release formulations and biorelevant dissolution testing
• European Pharmacopoeia (EP) 2.9.3. and 2.9.4., specifying standardized procedures for solid dosage forms and transdermal patches
• Japanese Pharmacopoeia (JP) 6.09, harmonized with global standards while maintaining regional requirements
• International Council for Harmonisation (ICH) guidelines, ensuring consistency across regulatory bodies
• Good Manufacturing Practice (GMP) requirements, with full compliance to data integrity standards (e.g., 21 CFR Part 11)

PharmaAnalytica's Technology Platform

PharmaAnalytica's Dissolution & Release Test

PharmaAnalytica's dissolution/release testing services stand out in the industry through our unwavering commitment to quality, efficiency, and client-centric support. Our core advantages include:

Uncompromising Precision and Reproducibility

Our integration of premium instruments—paired with rigorous method validation, calibration, and quality control—ensures test results with minimal variability. Every assay undergoes triple verification: instrument calibration, sample preparation accuracy checks, and data review by senior scientists, guaranteeing the reliability of results for regulatory submissions and clinical decision-making.

Full Regulatory Compliance

Our services align with USP, EP, JP, and GMP standards, with complete documentation packages including method validation reports, calibration certificates, and data integrity records. Our team of regulatory experts works closely with clients to ensure compliance with regional requirements, reducing the risk of delays or rejections during regulatory submissions.

Regulatory-Ready Data Packages

PharmaAnalytica offers competitive pricing without compromising quality. We provide transparent, fixed-cost service packages with no hidden fees, making our expertise accessible to pharmaceutical startups, CDMOs, and multinational corporations alike.

End-to-End Expert Support

From method development and validation to routine testing and regulatory consultation, PharmaAnalytica offers a comprehensive suite of services tailored to each client's unique needs. Our team of PhD-level scientists provides ongoing technical support, including guidance on formulation optimization, dissolution profile comparison, and IVIVC (In Vitro-In Vivo Correlation) development, ensuring clients maximize the value of their testing data.

At PharmaAnalytica, dissolution/release testing is more than a service—it is a commitment to advancing safe, effective pharmaceuticals worldwide. By combining state-of-the-art domestic instrumentation, rigorous scientific standards, and client-focused support, we deliver precise, reliable results that drive formulation success, ensure regulatory compliance, and ultimately improve patient outcomes. Whether you are developing a novel drug candidate, optimizing an existing formulation, or scaling production for global markets, PharmaAnalytica is your trusted partner for comprehensive dissolution/release testing solutions.